Category: cancer-cats

Brain tumour or cancer

Brain tumours in dogs are unfortunately as common as they are in people. Brain tumours can be devastating diseases and sadly cannot be cured in most animals. At present the only options for treatment are to improve the animal’s quality of life and help them to live for as long as possible. Unfortunately all brain tumours are eventually fatal diseases.

A tumour (or cancer) is a growth of abnormal cells within a body tissue. Tumours in the brain can develop from brain cells (primary brain tumour) that have started to grow uncontrollably or the tumour may be the result of spread of a tumour elsewhere in the body.

Common primary brain tumours include tumour arising from cells forming the lining of the surface of the brain (meningioma), the lining of ventricle (ependymoma), the choroid plexus (choroid plexus tumour) or the brain parenchyma itself (glioma). Fragments of tumours elsewhere in the body can break off from their primary source and travel in the blood to the brain where they settle and start to grow.

The signs seen in animals with brain tumours are usually the result of the tumour growing and causing pressure on the surrounding normal brain tissue. This causes brain damage and inflammation.

Brain tumours can cause a wide variety of clinical signs which vary according to the part of the brain that is affected. Often the first sign to develop is seizures (fits). These seizures are often very severe causing the dog to collapse, salivate profusely, thrash around and occasionally void its bowels and bladder. Unfortunately, these seizures are likely to be permanent.

Other signs commonly seen are blindness, changes in the dog’s personality, profound lethargy, circling and disorientation. Some people may notice that their dog appears to have a ‘headache’. As with seizures, some of these signs may be permanent whatever the treatment course that you decide upon.

Your vet may suspect that your pet has a brain tumour because of the signs you describe. The brain cannot be seen on standard X-rays so special diagnostic tests are needed to allow your vet to take pictures of your pets brain.

Diagnosis of brain tumours is based on imaging the brain either with a CT-scan or an MRI-scan. Although these tests are very good for detecting the presence of a mass in the brain, they are not good at identifying the exact nature of this mass (i.e. whether it is a tumour, inflammation or even bleeding within the brain).

A sample of the fluid from around the brain may need to be taken to rule-out an inflammation of the brain and, in rare cases this can reveal the presence of a certain type of tumour called lymphoma. In order to confirm the exact cause of the mass and – if it is a tumour – to find out how malignant it is, a tissue sample must be collected. This sample can be obtained by inserting a biopsy needle through the skull. If surgical removal of the mass is planned a sample may simply be collected at the time of surgery.

Aggressive tumours may spread around the body (metastasise). Brain tumours can spread to the chest, and tumours from other sites (especially lung, liver, prostate, and mammary gland) may spread to the brain. X-Rays of the chest and abdomen as well as abdominal ultrasound may be necessary to confirm that the tumour is not elsewhere in the body.

Advances in veterinary care for pets mean that brain tumours can be treated, although unfortunately there are few tumours which can be cured. Treatment is usually aimed at providing your pet with the best possible quality of life for as long as possible. Whatever treatment course you decide upon, if your dog is having seizures they should be given medication to control these as the seizures are likely to be permanent.

The treatment and prognosis for brain tumours vary with the type of tumour. The most appropriate treatment for an individual depends on a number of factors, including the type of tumour and the general health of the patient. There are 3 basic options for the treatment of tumours:

Medication alone

There are few chemotherapy options for brain tumours because the brain is a very protected site and most drugs cannot penetrate it. However treatment may help to reduce some of the signs seen in a patient with a brain tumour.

A combination of anti-inflammatory medication (corticosteroids) to reduce the swelling and pressure caused by the tumour, and drugs to reduce the severity and frequency of seizures can be prescribed. In some cases this may relieve a lot of the symptoms and make the animal feel a lot better. However, animals on this combination of drugs are often very thirsty and hungry and may need to go to the toilet more often occasionally this can cause problems with wetting in the house.

The drugs used to control seizures may initially make your pet more sleepy but most dogs get used to the drugs after a couple of weeks. This approach does not cost much and there is little risk of making your pet worse, however, in some cases this may only provide relief for a couple of months.

Medication and radiation therapy

While many brain tumours in dogs are relatively benign and amenable to surgery, some are deep seated and therefore pose significant surgical risks. Radiation therapy can result in dramatic and rapid improvement of signs. The benefits of this treatment far outweigh the risks in most pets. Most animals suffer any side-effects from the radiation treatment but these might include; occasional nausea, mouth ulcers, ear infection or, rarely, blindness. Most of the side-effects of radiation can be controlled with additional medication.

The advantage of using radiation treatment in addition to medication is that it can provide a longer period of good quality of life than with medication alone. Unfortunately, radiation rarely completely destroys the tumour and average remission times are 8 to 14 months before the tumour recurs.

Medication, radiation therapy and surgery

The ultimate goal of cancer surgery is to remove the tumour completely. Unfortunately, this is rarely possible with brain tumours and there are nearly always tumour cells left behind which cause the tumour to regrow. However, by removing as much of the tumour as possible at surgery, the remaining cells may become more sensitive to radiation. The polytherapy approach (combination of medication, surgery and radiation) is the mainstay of treatment for most brain tumours in humans. The aim of treatment is to remove the bulk of the tumour by surgery to give other therapies a better chance of success.

Surgery also allows the vet to obtain a sample of the mass and identify its nature, which may make it easier to give a more accurate prediction of how well the patient is likely to do. Not all brain tumors can be removed surgically, practicality depends on their position within the brain. Tumours that are on the brain surface are more likely to be amenable to surgery. To reach a tumour deep within the brain the surgeon would have to cut through a large area of healthy brain tissue and this could have devastating effects for the recovery of the patient.

Surgery is the most invasive and costly option. Although many dogs recover well and without complication brain surgery can (on rare occasions) cause irreversible damage to the brain. Some owners report that their pet’s personality and behaviour has changed after surgery. Brain surgery does carry a risk, particularly if the patient has other health problems as a lengthy anaesthetic is needed. Occasionally the patient may not recover from the surgery. The benefits of this option are that it potentially offers the longest period of quality of life for your pet.

The aim of treatment for a brain tumour in pets is to prolong the period in which they enjoy a good quality of life. Your vet will not want to prolong your pet’s life if your pet is unhappy. Discuss all your concerns with your vet before your pet starts treatment and at every stage of the course. It will always be your decision as to when your pet is no longer happy. At this time the best option for your pet will be to ask your vet to put him or her to sleep.

Predicting how long your animal can live with a brain tumour can be very difficult as this estimation depends on many factors including the type of tumour (which determines how quickly it grows), its size and place within the brain and finally the treatment used. Although many animals survive only a matter of months after diagnosis of a brain tumour, with help they can have a good quality of life.

If you decide to opt for treatment this time may help you to come to terms with what is happening to your pet and to have some happy memories to keep. As a rough guide, average remission time ranges from 1 to 6 months with corticosteroids alone, from 8 to 14 months with radiotherapy alone and 12 to 20 months with surgery followed by radiotherapy.

Anal sac gland carcinoma

Anal sac gland carcinoma (also known as apocrine gland carcinoma of the anal sacs and anal sac adenocarcinoma) is a malignant tumour of the anal sacs of the dog. It is a relatively uncommon tumour but it is seen with increased frequency in English Cocker Spaniels in particular and other spaniels to a lesser degree.

The anal sacs are 2 scent glands located either side of the anus in the dog. They are usually emptied when a motion is passed. In some dogs a tumour develops in the glandular tissue in the sacs. The fact that the disease is more common in some breeds of dogs suggests that genetic factors are involved but no one really knows for sure why some dogs develop the disease. In many cases this is the only site in which the tumour is growing but sometimes the tumour may spread to the lymph nodes or via the bloodstream to places like the lungs, liver and spleen.

A large proportion of these tumours are discovered by chance when a dog is presented for evacuation of the anal sacs. Sometimes the dogs develop irritation of the anal sacs which prompts this check in the first place, though this is unusual. In some cases owners actually see a swelling under the tail and next to the anus but it is rare for the tumour to grow big enough to cause problems at the original site.

You may notice changes in your pet that reflect spread of the tumour or are a consequence of substances produced by the tumour. Sometimes these tumours produce a hormone that causes excessive drinking and urination. This may be the only problem evident prior to diagnosis of the tumour.

Your vet may suspect the disease from examination of your pet and may be able to feel a swelling in the gland on rectal examination of your dog. In order to plan the most appropriate treatment, your vet will want to know the extent of the tumour. They will want to take samples if they suspect that the tumour has spread to the lymph nodes or to other organs. In addition they will want to take some blood tests and may need to check blood calcium levels as this is related to the hormone disturbance noted above.

The presence or absence of spread can be determined by X-rays and ultrasound examinations. These can usually be performed under light sedation.

There are a number of treatment options available for the management of anal sac gland carcinoma. Decisions are made on the basis of a number of factors, primarily whether and where the tumour has spread at diagnosis.

For patients with small (less than 3cm diameter) tumours and no evidence of spread of the tumour, surgical removal of the tumour is likely to be the most appropriate therapy. For patients where the tumour cannot be completely removed, radiotherapy can be used post-operatively to improve the tumour control.

For patients with larger primary tumours but still no evidence of spread, chemotherapy can be used to attempt to shrink the tumour, before surgery. This makes the surgery easier and may reduce the risk of post-operative complications. Again, radiotherapy may be appropriate following surgery to improve the duration of the resulting complete remission.

In some patients, where the tumour has spread to the lymph nodes but no further, the treatment plan is determined by whether or not those enlarged lymph nodes can be removed surgically. As always, the aim is to achieve optimal quality of life first and foremost and a good long life second. Therefore, if it is apparent that the enlarged lymph nodes can be removed without causing undue risk, they are removed.

If the lymph nodes look like they cannot be removed in their entirety or without presenting the patient with undue risk, they can be left or managed by either chemotherapy or radiotherapy or sometimes by a combination of these. Subsequent surgery can be performed in these dogs to remove other lymph nodes that become enlarged months or years in the future.

The average life expectancy for a dog with a small tumour that is removed by surgery is three years and three months. Dogs with larger tumours that have chemotherapy before surgery have an average life expectancy of two years.

For patients where the lymph nodes are involved but they can be removed there is an average life expectancy of sixteen months. If the lymph nodes cannot be removed then sadly less than 50% of these patients live more than 12 months from the time of diagnosis but as before, their quality of life is paramount during this time and measures are always being taken to ensure their well-being.

The final group of patients is the group with cancer that has spread throughout their body. Of course this is the worst case scenario but even in this situation patients can enjoy a normal quality of life for long periods of time with appropriate management.

Despite the gravity of a diagnosis of malignant cancer, some patients can enjoy an extremely prolonged period of complete normality and an excellent quality of life with appropriate therapy.

Anal sac gland carcinoma

Anal sac gland carcinoma (also known as apocrine gland carcinoma of the anal sacs and anal sac adenocarcinoma) is a malignant tumour of the anal sacs of the dog. It is a relatively uncommon tumour but it is seen with increased frequency in English Cocker Spaniels in particular and other spaniels to a lesser degree.

The anal sacs are 2 scent glands located either side of the anus in the dog. They are usually emptied when a motion is passed. In some dogs a tumour develops in the glandular tissue in the sacs. The fact that the disease is more common in some breeds of dogs suggests that genetic factors are involved but no one really knows for sure why some dogs develop the disease. In many cases this is the only site in which the tumour is growing but sometimes the tumour may spread to the lymph nodes or via the bloodstream to places like the lungs, liver and spleen.

A large proportion of these tumours are discovered by chance when a dog is presented for evacuation of the anal sacs. Sometimes the dogs develop irritation of the anal sacs which prompts this check in the first place, though this is unusual. In some cases owners actually see a swelling under the tail and next to the anus but it is rare for the tumour to grow big enough to cause problems at the original site.

You may notice changes in your pet that reflect spread of the tumour or are a consequence of substances produced by the tumour. Sometimes these tumours produce a hormone that causes excessive drinking and urination. This may be the only problem evident prior to diagnosis of the tumour.

Your vet may suspect the disease from examination of your pet and may be able to feel a swelling in the gland on rectal examination of your dog. In order to plan the most appropriate treatment, your vet will want to know the extent of the tumour. They will want to take samples if they suspect that the tumour has spread to the lymph nodes or to other organs. In addition they will want to take some blood tests and may need to check blood calcium levels as this is related to the hormone disturbance noted above.

The presence or absence of spread can be determined by X-rays and ultrasound examinations. These can usually be performed under light sedation.

There are a number of treatment options available for the management of anal sac gland carcinoma. Decisions are made on the basis of a number of factors, primarily whether and where the tumour has spread at diagnosis.

For patients with small (less than 3cm diameter) tumours and no evidence of spread of the tumour, surgical removal of the tumour is likely to be the most appropriate therapy. For patients where the tumour cannot be completely removed, radiotherapy can be used post-operatively to improve the tumour control.

For patients with larger primary tumours but still no evidence of spread, chemotherapy can be used to attempt to shrink the tumour, before surgery. This makes the surgery easier and may reduce the risk of post-operative complications. Again, radiotherapy may be appropriate following surgery to improve the duration of the resulting complete remission.

In some patients, where the tumour has spread to the lymph nodes but no further, the treatment plan is determined by whether or not those enlarged lymph nodes can be removed surgically. As always, the aim is to achieve optimal quality of life first and foremost and a good long life second. Therefore, if it is apparent that the enlarged lymph nodes can be removed without causing undue risk, they are removed.

If the lymph nodes look like they cannot be removed in their entirety or without presenting the patient with undue risk, they can be left or managed by either chemotherapy or radiotherapy or sometimes by a combination of these. Subsequent surgery can be performed in these dogs to remove other lymph nodes that become enlarged months or years in the future.

The average life expectancy for a dog with a small tumour that is removed by surgery is three years and three months. Dogs with larger tumours that have chemotherapy before surgery have an average life expectancy of two years.

For patients where the lymph nodes are involved but they can be removed there is an average life expectancy of sixteen months. If the lymph nodes cannot be removed then sadly less than 50% of these patients live more than 12 months from the time of diagnosis but as before, their quality of life is paramount during this time and measures are always being taken to ensure their well-being.

The final group of patients is the group with cancer that has spread throughout their body. Of course this is the worst case scenario but even in this situation patients can enjoy a normal quality of life for long periods of time with appropriate management.

Despite the gravity of a diagnosis of malignant cancer, some patients can enjoy an extremely prolonged period of complete normality and an excellent quality of life with appropriate therapy.